ABSTRACT
INTRODUCTION
Microvascular obstruction (MVO) during primary percutaneous coronary intervention (pPCI) for acute ST-segment elevation myocardial infarction (STEMI), occurs in approximately 40-50% of patients with successfully restored epicardial artery flow and has been proved to be associated with adverse ventricular remodeling and heart failure. [1] [2] [3] So far, none of the available prophylactic and therapeutic strategies have been shown to be effective in the treatment of MVO. [1] [2] [3] [4] [5] As a thrombus is considered to be the primary cause of the development of MVO, catheter retrieval of thrombotic material, known as manual thrombus aspiration (TA), is currently considered the most useful means of preventing an MVO during pPCI.
CLINICAL TRIALS ON THROmBUS ASPIRATION
Several clinical trials have investigated TA and have tried to identify the best therapeutic strategy which would avoid this complication associated with pPCI.
One of the leading clinical trials that examined the role of TA was the TAPAS trial (Cardiac death and reinfarction after one year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study) [NCT01013038] , which aimed at determining if, in patients with STEMI, TA, before stent implantation, improves myocardial perfusion compared to conventional pPCI. 6 The study demonstrated a significantly lower rate of cardiac death (3.6% vs. 
COmmERCIAL DEvICES fOR THROmBUS ASPIRATION
In order to clarify these controversies, consideration has been directed at physical or technical factors in addition to randomized clinical trials. Hara et al. compared the in vitro performances of six and seven French guide catheters from six manufacturers. 19 They noted that the rigidity of the aspired material, its shape and deformability and its surface properties were linked to frictional resistance, as well as the form of the catheter lumen.
Differences in the frictional resistance associated with 
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The most comprehensive study on the effects of catheter tip design and rheological properties of a thrombus on the TA efficiency was conducted by Sajjad SoleimaniAmiri. 23 After thorough experimental investigations of the rheological properties of the clot, a CFD model based on several tip designs and clot rheological models was developed. The study indicated that a catheter with side holes performed better for fresh, lower viscosity clot, whereas older clots of higher viscosity were better treated with catheters without side holes. Regarding tip design, the simulations indicated that the catheter with a right-angle tip performed better on clot aspiration, although most of the commercial catheters feature a beveled tip.
Based on these studies it may be concluded that, when it comes to absorbing older clots from a coronary artery, the efficiency of the TA devices is poor. Thrombus age appears to be critical because a fresh thrombus is considered the primary cause of distal microcirculation obstruction.
An OCT sub-study of the largest thrombectomy trial (TOTAL) has shown that in patients undergoing pPCI for STEMI, manual thrombectomy did not reduce the pre-stent thrombus burden when compared to PCI-alone. Moreover, both groups were associated with a low thrombus burden before the primary revascularization procedure.
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DISTAL PROTECTION DEvICES IN THE PREvENTION Of mvO
The EMERALD and DEDICATION studies considered the role of distal protection devices in the prevention of MVO.
The EMERALD trial (Enhanced Myocardial Efficacy and
Recovery tection. 26 The results of these trials were disappointing, as no differences were shown between the groups regarding the primary end-point which consisted of incomplete or >70% ST-segment resolution (p = 0.29), or secondary end-points such as infarct size or MVO surrogate parameters. 26, 27 It was concluded that intra-procedural embolism during PCI might be less relevant for MVO and the determination of infarct size. Several published data using Doppler guide wire detection suggested that only a small number of emboli occur during a PCI procedure, confirming the above-mentioned hypothesis.
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TImING fOR THROmBUS ASPIRATION
Considering these data, alternative approaches regarding the timing of embolism and the composition of embolic material require to be considered. In a study published by
Kramer et al., 40% of the patients had an old thrombus in materials extracted using TA. 29 with alteplase. 34 The study used the Rankin scale to evaluate the severity of global disability at ninety days, ranging from 0 points to 6 points (no symptoms → to death). The study revealed that thrombectomy reduced the severity of the disability. In the TA group, 43.7% of patients scored between 0-2 on the modified Rankin scale at ninety days compared to 28.2% of the patients with only drug therapy (p = 0.02), proving that TA was associated with improved functional outcomes and higher rates of angiographic revascularization.
34
CONCLUSIONS
The leading cause of MVO is represented by the thrombus embolization occurring during coronary angioplasty procedures. TA is a technique that prevents the complications of MVO, decreasing the mortality in STEMI patients treated with pPCI. However, the efficacy of TA is largely based on the configuration of the absorption catheter. Nowadays, the indications of TA have been expanded to acute stroke, improving the outcomes obtained in the treatment of this devastating disease.
Finally, we agree with James C. Blankenship that "Oculo-thrombotic Reflex, Why We Will Never Stop Aspirating
Coronary Thrombi", because of the emotional aspect of this issue. 35 
